메뉴 건너뛰기




Volumn 116, Issue 6, 2015, Pages 905-910

Perioperative outcomes of cytoreductive nephrectomy in the UK in 2012

Author keywords

cytoreductive; nephrectomy; outcomes; perioperative

Indexed keywords

PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

EID: 84946498887     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12890     Document Type: Article
Times cited : (29)

References (13)
  • 1
    • 84862861309 scopus 로고    scopus 로고
    • Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: Who and when
    • Bex A, Powles T,. Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when. Expert Rev Anticancer Ther 2012; 12: 787-97
    • (2012) Expert Rev Anticancer Ther , vol.12 , pp. 787-797
    • Bex, A.1    Powles, T.2
  • 2
    • 0035818877 scopus 로고    scopus 로고
    • Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
    • Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001; 345: 1655-9
    • (2001) N Engl J Med , vol.345 , pp. 1655-1659
    • Flanigan, R.C.1    Salmon, S.E.2    Blumenstein, B.A.3
  • 3
    • 0035934596 scopus 로고    scopus 로고
    • Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: A randomised trial
    • European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group
    • Mickisch GHJ, Garin A, van Poppel H, de Prijck L, Sylvester R, European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358: 966-70
    • (2001) Lancet , vol.358 , pp. 966-970
    • Mickisch, G.H.J.1    Garin, A.2    Van Poppel, H.3    De Prijck, L.4    Sylvester, R.5
  • 6
    • 84946494890 scopus 로고    scopus 로고
    • National Library of Medicine (US). Accessed October 2014
    • National Library of Medicine (US). Clinical Trial to Assess the Importance of Nephrectomy (CARMENA). 2010. Available at: http://clinicaltrials.gov/show/NCT00930033. Accessed October 2014
    • (2010) Clinical Trial to Assess the Importance of Nephrectomy (CARMENA)
  • 7
    • 84925229611 scopus 로고    scopus 로고
    • Perioperative outcomes of 6042 nephrectomies in 2012: Surgeon-reported results in the UK from the British Association of Urological Surgeons (BAUS) nephrectomy database
    • BAUS
    • Henderson JM, Fowler S, Joyce A, Dickinson A, Keeley FX, BAUS. Perioperative outcomes of 6042 nephrectomies in 2012: surgeon-reported results in the UK from the British Association of Urological Surgeons (BAUS) nephrectomy database. BJU Int 2015; 115: 121-6
    • (2015) BJU Int , vol.115 , pp. 121-126
    • Henderson, J.M.1    Fowler, S.2    Joyce, A.3    Dickinson, A.4    Keeley, F.X.5
  • 8
    • 3242713145 scopus 로고    scopus 로고
    • Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    • Dindo D, Demartines N, Clavien PA,. Classification of surgical complications-a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213
    • (2004) Ann Surg , vol.240 , pp. 205-213
    • Dindo, D.1    Demartines, N.2    Clavien, P.A.3
  • 9
    • 84893687131 scopus 로고    scopus 로고
    • Do targeted agents offer clinical benefit as presurgical therapy?
    • Bex A, Haanen J,. Do targeted agents offer clinical benefit as presurgical therapy? World J Urol 2014; 32: 3-8
    • (2014) World J Urol , vol.32 , pp. 3-8
    • Bex, A.1    Haanen, J.2
  • 11
    • 84876463221 scopus 로고    scopus 로고
    • In-hospital mortality and failure to rescue after cytoreductive nephrectomy
    • Trinh QD, Bianchi M, Hansen J, et al. In-hospital mortality and failure to rescue after cytoreductive nephrectomy. Eur Urol 2013; 63: 1107-14
    • (2013) Eur Urol , vol.63 , pp. 1107-1114
    • Trinh, Q.D.1    Bianchi, M.2    Hansen, J.3
  • 12
    • 85007033817 scopus 로고    scopus 로고
    • Number of metastatic sites and perioperative outcomes after cytoreductive nephrectomy: A population-based analyses
    • Bianchi M, Trinh QD, Sun M, et al. Number of metastatic sites and perioperative outcomes after cytoreductive nephrectomy: a population-based analyses. J Urol 2012; 187: E724
    • (2012) J Urol , vol.187 , pp. E724
    • Bianchi, M.1    Trinh, Q.D.2    Sun, M.3
  • 13
    • 84867725031 scopus 로고    scopus 로고
    • Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC)
    • Silberstein JL, Adamy A, Maschino AC, et al. Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC). BJU Int 2012; 110: 1276-82
    • (2012) BJU Int , vol.110 , pp. 1276-1282
    • Silberstein, J.L.1    Adamy, A.2    Maschino, A.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.